Klaus Elenius

Abstract 3500: A pipeline to identify driver mutations

Laura L. Elo, Deepankar Chakroborty, Kari Kurppa, 2018 .

Role of ErbB4 in Breast Cancer

Sami Kilpinen, Kristiina Iljin, Klaus Elenius, 2008, Journal of Mammary Gland Biology and Neoplasia.

Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells

Na Zhang, Klaus Elenius, Maria Sundvall, 2006, Clinical Cancer Research.

Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.

Jorma Isola, Klaus Elenius, Tapio Visakorpi, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.

Jorma Isola, Mikala Egeblad, Klaus Elenius, 2005, Molecular biology of the cell.

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.

Jorma Isola, Klaus Elenius, J. Isola, 2004, Molecular cancer therapeutics.

ErbB4 is downregulated in renal cell carcinoma A quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family

Börje Ljungberg, Klaus Elenius, Marcus Thomasson, 2004, Acta oncologica.

Somatic Mutations of ErbB4

Klaus Elenius, Susanna Repo, Maria Sundvall, 2009, Journal of Biological Chemistry.